安科生物
(300009)
| 流通市值：108.75亿 | | | 总市值：147.74亿 |
| 流通股本：12.30亿 | | | 总股本：16.71亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 174,504,955.49 | 250,202,239.26 | 187,132,175.54 | 327,468,539.04 |
| 交易性金融资产 | 1,418,343,860.56 | 1,191,953,897.57 | 1,123,258,275 | 749,000,090.37 |
| 应收票据及应收账款 | 433,106,965.01 | 407,943,261.88 | 430,565,498.76 | 443,951,827.61 |
| 应收账款 | 433,106,965.01 | 407,943,261.88 | 430,565,498.76 | 443,951,827.61 |
| 应收款项融资 | 62,695,903.98 | 87,620,594.08 | 70,442,379.52 | 77,324,587.84 |
| 预付款项 | 14,969,513.92 | 10,534,603.06 | 26,938,067.55 | 26,038,571.72 |
| 其他应收款合计 | 49,958,651.1 | 35,163,419.29 | 38,170,592.94 | 32,876,171.85 |
| 存货 | 274,215,582.35 | 252,754,226.91 | 276,602,348.38 | 284,313,076.96 |
| 一年内到期的非流动资产 | 64,862,333.34 | 141,072,638.9 | 140,063,194.43 | 139,053,750 |
| 其他流动资产 | 16,902,394.6 | 17,829,463.16 | 450,990.06 | 648,911.51 |
| 流动资产合计 | 2,509,560,160.35 | 2,395,074,344.11 | 2,293,623,522.18 | 2,080,675,526.9 |
| 非流动资产: | | | | |
| 债权投资 | 104,684,666.67 | 104,044,666.67 | 103,390,444.44 | 102,736,222.22 |
| 长期股权投资 | 146,115,840.98 | 150,955,638.5 | 116,636,719.42 | 120,816,695.82 |
| 其他权益工具投资 | 409,190,487.84 | 380,719,660.31 | 119,974,701.8 | 127,734,647.82 |
| 其他非流动金融资产 | 153,564,474.12 | 153,564,474.12 | 152,976,435.02 | 152,976,435.02 |
| 投资性房地产 | 6,807,006.39 | 7,864,401.5 | 7,793,093.88 | 8,036,196.82 |
| 固定资产 | 983,721,854.53 | 972,048,369.33 | 930,512,114.73 | 708,563,079.65 |
| 在建工程 | 588,696,348.53 | 620,769,552.32 | 614,993,680.36 | 838,872,065.97 |
| 使用权资产 | 29,967,837.53 | 31,808,733.22 | 28,766,117.28 | 37,988,646.69 |
| 无形资产 | 385,720,770.62 | 393,662,228.44 | 399,743,622.43 | 407,757,571.43 |
| 开发支出 | 202,042,898.29 | 198,869,491.79 | 195,543,428.28 | 194,177,431.53 |
| 商誉 | 66,556,732.24 | 66,556,732.24 | 66,556,732.24 | 66,556,732.24 |
| 长期待摊费用 | 6,864,531.54 | 5,926,124.77 | 6,330,726.85 | 17,465,581.96 |
| 递延所得税资产 | 60,136,276.28 | 61,504,791.56 | 48,092,562.03 | 44,135,209.52 |
| 其他非流动资产 | 10,975,147.96 | 4,284,199.92 | 15,690,309.62 | 14,470,879.95 |
| 非流动资产合计 | 3,155,044,873.52 | 3,152,579,064.69 | 2,807,000,688.38 | 2,842,287,396.64 |
| 资产总计 | 5,664,605,033.87 | 5,547,653,408.8 | 5,100,624,210.56 | 4,922,962,923.54 |
| 流动负债: | | | | |
| 短期借款 | - | - | - | 7,000,000 |
| 应付票据及应付账款 | 207,501,992.25 | 252,277,019.05 | 187,841,693.77 | 204,313,688.85 |
| 其中：应付票据 | 27,190,000 | 31,420,000 | 20,000,000 | 20,000,000 |
| 应付账款 | 180,311,992.25 | 220,857,019.05 | 167,841,693.77 | 184,313,688.85 |
| 合同负债 | 13,250,177.49 | 8,085,093.79 | 21,355,188.87 | 18,936,825.52 |
| 应付职工薪酬 | 110,395,754.17 | 103,957,602.58 | 80,854,940.74 | 77,053,901.28 |
| 应交税费 | 77,252,216.8 | 73,426,264.27 | 79,158,672.27 | 61,336,508.71 |
| 其他应付款合计 | 166,431,762.74 | 193,688,630.33 | 227,982,026.44 | 239,527,651.36 |
| 应付股利 | 771,552 | 10,627,347 | 10,627,347 | 10,627,347 |
| 一年内到期的非流动负债 | 7,821,784.36 | 7,664,748.21 | 7,613,647.69 | 9,332,873.97 |
| 其他流动负债 | 891,332.59 | 600,859.83 | 1,821,035.12 | 1,908,951.01 |
| 流动负债合计 | 583,545,020.4 | 639,700,218.06 | 606,627,204.9 | 619,410,400.7 |
| 非流动负债: | | | | |
| 租赁负债 | 22,418,040.81 | 25,291,823.91 | 23,024,986.99 | 31,500,406.26 |
| 预计负债 | 2,311,638.93 | 2,311,638.93 | - | - |
| 递延收益 | 125,265,553.73 | 123,427,938.2 | 118,190,165.87 | 120,284,763.8 |
| 递延所得税负债 | 26,529,709.09 | 20,565,152.74 | 7,800,352.76 | 8,046,043.91 |
| 非流动负债合计 | 176,524,942.56 | 171,596,553.78 | 149,015,505.62 | 159,831,213.97 |
| 负债合计 | 760,069,962.96 | 811,296,771.84 | 755,642,710.52 | 779,241,614.67 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,671,320,708 | 1,672,521,258 | 1,672,521,258 | 1,672,521,258 |
| 资本公积 | 449,393,714.26 | 459,497,791.32 | 457,405,522.33 | 463,845,241.89 |
| 减:库存股 | 8,321,280 | 14,554,154.5 | 74,354,275.6 | 102,041,772.73 |
| 其他综合收益 | 87,027,001.01 | 64,761,046.22 | -78,746,995.87 | -71,008,287.24 |
| 盈余公积 | 503,427,398.18 | 503,427,398.18 | 437,655,411.59 | 437,655,411.59 |
| 未分配利润 | 2,040,600,758.97 | 1,872,361,712.07 | 1,754,424,259.02 | 1,569,458,163.32 |
| 归属于母公司股东权益合计 | 4,743,448,300.42 | 4,558,015,051.29 | 4,168,905,179.47 | 3,970,430,014.83 |
| 少数股东权益 | 161,086,770.49 | 178,341,585.67 | 176,076,320.57 | 173,291,294.04 |
| 股东权益合计 | 4,904,535,070.91 | 4,736,356,636.96 | 4,344,981,500.04 | 4,143,721,308.87 |
| 负债和股东权益合计 | 5,664,605,033.87 | 5,547,653,408.8 | 5,100,624,210.56 | 4,922,962,923.54 |
| 公告日期 | 2026-04-24 | 2026-03-31 | 2025-10-28 | 2025-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |